Recipients › Utah › Biofire Defense LLC
Recipient organisation · UEI NHMDGM122546
Biofire Defense LLC
USAspending caveat. Figures are obligations reported by federal agencies to USAspending.gov, not payments. In USAspending's words: "An outlay occurs when federal money is actually paid out, not just promised to be paid ('obligated')." "Every agency has a Senior Accountable Official who must officially certify that the quarterly financial data submitted by their agency is accurate and complete." "If there are any discrepancies in procurement data, FPDS is the authoritative source." Contract data for the Department of Defense and the U.S. Army Corps of Engineers is published with a 90-day delay. Data loaded 30 Sep 2026. View the USAspending recipient profile.
Biofire Defense LLC, of Salt Lake City, UT, was obligated $54M in federal awards across the 4 fiscal years in which it reached the $1.0M listing floor (2023, 2024, 2025, 2026).
In FY2026, the most recent complete fiscal year, obligations were $6.5M, of which $6.5M (100%) came through contracts.
That is down 23% on FY2025 ($8.4M).
Biofire Defense LLC ranks 92 of 289 listed organisations located in UT by five-year obligations, and 9,076 of 30,989 nationally.
Its $1.0M-plus awards since FY2023 came from Department of Health and Human Services and Department of Defense: 8 awards worth $32M in total award value.
Its largest contract industry is NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)), where it ranks 44 of 174 organisations by the value of $1.0M-plus awards.
Obligations by fiscal year contracts vs assistance
| Fiscal year | All obligations | Contracts | Assistance | Change |
|---|---|---|---|---|
| FY2023 | $31,627,541 | $31,627,541 | $0 | — |
| FY2024 | $7,332,127 | $7,332,127 | $0 | -77% |
| FY2025 | $8,425,711 | $8,164,343 | $261,368 | +15% |
| FY2026 | $6,492,592 | $6,492,592 | $0 | -23% |
| FY2027 to date | under $1.0M | — | — | — |
A fiscal year runs 1 October to 30 September. "Contracts" are procurement award types A–D; "assistance" is everything else (grants, direct payments, loan subsidy cost, insurance, other). The contracts column is listed only where contract obligations alone reached $1.0M; the assistance figure is the remainder and may therefore include up to $1.0M of contracts.
Compared with its state and the largest recipients five listed years
| Measure | This organisation | Largest in UT | Largest nationally |
|---|---|---|---|
| Five-year obligations (listed years) | $54M | $15B | $416B |
| FY2026 obligations | $6.5M | $3.7B | $118B |
| Contracts, five years | $54M | under $1.0M | $94B |
| Assistance, five years | $261K | $15B | $416B |
| Rank by five-year obligations | 9,076 of 30,989 | 1 of 289 in UT | 1 |
Largest in state: Utah Department of Health and Human Services. Largest nationally: Health Care Services, California Department of. Rankings count organisations located in the state, by the sum of their listed fiscal years.
Awarding agencies $1.0M+ awards since FY2023
| # | Agency | Awards | Award value | Share |
|---|---|---|---|---|
| 1 | Department of Health and Human Services | 1 | $22M | 68% |
| 2 | Department of Defense | 7 | $10M | 32% |
Contract industries NAICS
Rank within NAICS 541714: 44 of 174 organisations by $1.0M+ award value; see Research and Development in Biotechnology (except Nanobiotechnology).
Places of performance $1.0M+ awards
Counties: Salt Lake County, UT $27M · Montgomery County, MD $1.5M · San Diego County, CA $1.5M · Bexar County, TX $1.3M · Harford County, MD $1.1M
Largest awards begun since FY2023
| Awarding agency | Type | Industry or program | Award value | Begun | Place | Record |
|---|---|---|---|---|---|---|
| Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response | ContractDefinitive Contract | 541714 Research and Development in Biotechnology (except Nanobiotechnology) | $22M | 29 Sep 2023 | UT | USAspending |
| Department of DefenseDepartment of the Army | ContractDelivery Order | 334516 Analytical Laboratory Instrument Manufacturing | $2.0M | 29 Mar 2024 | UT | USAspending |
| Department of DefenseDepartment of the Army | ContractDelivery Order | 334516 Analytical Laboratory Instrument Manufacturing | $1.9M | 24 Feb 2023 | UT | USAspending |
| Department of DefenseDefense Health Agency | ContractPurchase Order | 325413 In-Vitro Diagnostic Substance Manufacturing | $1.5M | 28 Sep 2024 | MD | USAspending |
| Department of DefenseDefense Health Agency | ContractPurchase Order | 334516 Analytical Laboratory Instrument Manufacturing | $1.5M | 14 Apr 2025 | CA | USAspending |
| Department of DefenseDepartment of the Army | ContractPurchase Order | 325413 In-Vitro Diagnostic Substance Manufacturing | $1.3M | 27 Jun 2025 | TX | USAspending |
| Department of DefenseDepartment of the Army | ContractDelivery Order | 334516 Analytical Laboratory Instrument Manufacturing | $1.2M | 22 Sep 2023 | UT | USAspending |
| Department of DefenseDepartment of the Army | ContractDelivery Order | 334516 Analytical Laboratory Instrument Manufacturing | $1.1M | 16 Nov 2022 | MD | USAspending |
Award value is the amount obligated to the award to date as USAspending reports it. Descriptions below are USAspending's text, unedited and truncated; those that appear to name a person are withheld.
- $22M, Department of Health and Human Services, 29 Sep 2023: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE BIOFIRE EMERGING FLU PANEL AS A NUCLEIC ACID DETECTION PANEL FOR USE ON THE EASY-TO-
- $2.0M, Department of Defense, 29 Mar 2024: THE OBJECTIVE OF THIS TASK IS TO UPDATE THE NEXT GENERATION DIAGNOSTICS SYSTEM INCREMENT 1 DEPLOYABLE COMPONENT SECURITY CLASSIFICATION GUIDE.
- $1.9M, Department of Defense, 24 Feb 2023: POLYMERASE CHAIN REACTION (PCR) IN VITRO
- $1.5M, Department of Defense, 28 Sep 2024: MOLECULAR DIAGNOSTICS KITS
- $1.5M, Department of Defense, 14 Apr 2025: MOLECULALR ASSAY ANALYZER
- $1.3M, Department of Defense, 27 Jun 2025: MOLECULAR INFECTIOUS DISEASE POLYMERASE CHAIN REACTION (PCR) TESTING
- $1.2M, Department of Defense, 22 Sep 2023: FEASIBILITY STUDY
- $1.1M, Department of Defense, 16 Nov 2022: FILMARRAY, AND WARRIOR KITS DELIVERY
Questions and answers
How much federal money does Biofire Defense LLC receive?
$54M in award obligations over the fiscal years it is listed for (FY2023: $32M; FY2024: $7.3M; FY2025: $8.4M; FY2026: $6.5M). Years not listed were under the $1.0M floor. Obligations are binding commitments, not payments made.
Which agencies award to Biofire Defense LLC?
By the value of $1.0M-plus awards begun since FY2023: Department of Health and Human Services ($22M) and Department of Defense ($10M).
What is the money for?
Contracts are classified under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology), NAICS 334516 Analytical Laboratory Instrument Manufacturing and NAICS 325413 In-Vitro Diagnostic Substance Manufacturing.
Where is the work performed?
Primary places of performance for its larger awards: UT ($27M), MD ($2.6M), CA ($1.5M) and TX ($1.3M).
Is Biofire Defense LLC a large federal recipient?
It ranks 9,076 of 30,989 organisations on this site by five-year obligations and 92 of 289 located in UT. The site covers organisations with at least $1.0M in a fiscal year; individuals are excluded.
Where does this data come from?
USAspending.gov (U.S. Treasury), award transactions as loaded on 30 Sep 2026; fiscal-year totals via the spending-by-category endpoint and award lists via the award search endpoint. The USAspending recipient profile is the authoritative record.
Provenance
Source: USAspending.gov API v2 (U.S. Department of the Treasury, Bureau of the Fiscal Service), CC0. Fiscal-year obligations from the spending-by-category recipient ranking by recipient state (listing floor $1.0M per year); awards from the award search endpoint (new awards of $1.0M or more by base obligation date); parent and business categories from the recipient profile where fetched. Closed fiscal years are snapshots taken after year end; FY2027 is refreshed on each build. Data loaded by USAspending on 30 Sep 2026. Individuals and sole proprietors are excluded at ingest. Errors in processing are corrected at the next build; see corrections and the methodology.